搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
JD Supra
6 小时
Ozempic Weight Loss Users at Risk of Gastroparesis and Other Stomach Problems, New Study ...
A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...
9 小时
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
Medical News Today
9 小时
GLP-1 drugs like Ozempic may protect brain health, several studies show
A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...
BioSpace
11 小时
Pressure Mounts on Novo Nordisk’s $16.5B Catalent Buy Amid FTC Review
Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could ...
phillyvoice.com
12 小时
Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for ...
Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...
12 小时
on MSN
Criminal Networks Cash In On Demand For Weight Loss Drugs, Authorities Say
Ozempic, Wegovy, and Eli Lilly And Co's (NYSE:LLY) Mounjaro and Zepbound have fueled an illicit market of counterfeit and ...
13 小时
Ozempic is driving up the cost of your health care, whether you can get your hands on it or not
Health-care costs are going up and and yet, workers may still not get the coverage they want — particularly when it comes to drugs like Ozempic.
17 小时
France won’t pay for weight loss drug Wegovy. What about other European countries?
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.
NBC Los Angeles
22 小时
Wegovy and Zepbound rival targeting ‘next generation' of obesity drugs, Zealand Pharma ...
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...
1 天
WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term ...
WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...
1 天
Surging demand leaves many without crucial diabetes and ADHD medications
The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...
1 天
Why Ozempic, Zepbound, and other weight-loss drug dupes carry risks
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈